35 / 158
Informaciones
Psiquiátricas
2020 - n.º
239
35
on brain scans from 20 cohorts world-
wide in the ENIGMA Major Depressive
Disorder Working Group. Molecular
Psychiatry 2017; (22):900-909
15. Lener MS, Iosifescu DV. In pursuit of
neuroimaging biomarkers to guide
treatment selection in major depressi-
ve disorder: a review of the literature.
Ann. N.Y. Acad. Sci. 2015;1344: 50–65
16. Dunlop BW, Mayberg HS. Neuroimaging
advances for depression. Cerebrum
2017; nov-dec:1-17
17. Wise T, Radua J, Nortje G, Cleare AJ,
Young AH and Arnone D. Voxel-Based
Meta-Analytical Evidence ot Structu-
ral Disconnectivity in Major Depres-
sion and Bipolar Disorder. Biological
Psychiatry 2016; 79:293-302
18. Williams LM. Precision psychiatry: a
neural circuit taxonomy for depression
and anxiety. Lancet Psychiatry 2016;
3(5):472-480
19. Zhang, K., Zhu, Y., Zhu, Y. ,Wu S, Liu
H, Zhang W et al. Molecular, Functio-
nal, and Structural Imaging of Major
Depressive Disorder. Neurosci. Bull.
2016; 32: 273-286
20. Capitanio S, Bauckneht M, Arnaldi D,
Massa F, Meli R, Ceriani V et al. FDG-
PET/CT in neurodegenerative disease.
In: Fraioli F, de. PET/CT in brain disor-
ders. Springer, Berlin 2019: 37-48.
21. Kaplan & Sadock. Manual de bolsillo de
Psiquiatría Clínica.Sadock BJ, Ahmad
S, Sadock VA. Eds. Wolters Kluwer.
Philadelphia, 2018.
22. Schwartz TL. Practical psychopharma-
cology.Basic to Advanced Principles.
Routledge, NewYork 2017.
23. Kok RM, Reynolds CF. Management of
depression in older adults. A Review.
JAMA 2017; 317(20):2114-2122.
LA DEPRESIÓN EN EL ANCIANO CON OJOS DE NEURÓLOGO